Fourteen different diagnoses, including sub-categories of neuroblastoma (NB; MYCN amplified and not amplified) and rhabdomyosarcoma (RMS; fusion positive and negative) were represented (Table 1; Table S1A). This evidence concerns the gene MYCN and neuroblastoma.